Mitochondria as pharmacological targets

    Research output: Contribution to journalArticlepeer-review


    In the last decade, mitochondria have provided a vast area of research for the pharmacologist, with a wealth of potential targets for drug action. Correct target identification and subsequent pharmacological manipulation might greatly help in the prevention and/or treatment of a number of the most prevalent diseases of our time including cancer, neurodegenerative disease and myocardial infarction. This is a commentary to accompany the publication of three papers in this issue of the BJP by Kurz et al., Pravdic et al. and Puerta et al. on different aspects of pharmacology involving mitochondria. © 2010 The British Pharmacological Society.
    Original languageEnglish
    Pages (from-to)217-219
    Number of pages2
    JournalBritish Journal of Pharmacology
    Issue number2
    Publication statusPublished - May 2010


    • Apoptosis
    • Cancer
    • Metabolic disease
    • Nitric oxide
    • Reactive oxygen species
    • Respiration
    • Signalling


    Dive into the research topics of 'Mitochondria as pharmacological targets'. Together they form a unique fingerprint.

    Cite this